Tellgen Corp300642
± MixedRegulationrelevance
Registration applications accepted, but no approval yet and no near-term impact.

Tellgen Life Sciences announced that six medical device registration applications submitted by the company and its controlling subsidiary Maishi Biotech have been accepted by the Shanghai Medical Products Administration. The six applications include four Alzheimer's disease auxiliary diagnostic kits and two mass spectrometry detection kits. The above products are still in the registration application acceptance stage and will not have an impact on recent performance.
Tellgen CorpRegistration applications accepted, but no approval yet and no near-term impact.
Subsidiary's applications accepted, but no approval yet and no near-term impact.